Recombinant Rituximab antibody (FITC)
Reactivity: Human
Host: Mouse
Monoclonal
FITC
Recombinant Antibody
-
- Target See all Rituximab products
- Rituximab
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Rituximab antibody is conjugated to FITC
- Application
- Please inquire
- Purpose
- FITC-Labeled Anti-Rituximab Antibody, Mouse IgG1
- Characteristics
- Anti-idiotypic Antibodies
- Immunogen
- FITC-Labeled Anti-Rituximab Antibodies, Mouse IgG1 are expressed from human 293 cells (HEK293).
- Isotype
- IgG1
-
anti-Rituximab antibody
Reactivity: Mouse FACS, EIA Host: Rat Monoclonal MB2 A4 unconjugated
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- -20°C, avoid light
-
- Target
- Rituximab
- Abstract
- Rituximab Products
- Target Type
- Antibody
- Background
- Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids
-
You are here:
